China's Packaging Machinery Market Research Report - PMMI

equipment, medical dressing, western medicine, biological medicine decreased
month by month.
The Future of China’s Pharmaceutical Industry
1. The whole industry keeps increasing at a high speed--a rate of 10~12%.
With the reform of China’s Medical Care system and improvement of the
people’s living standards, the pharmaceutical costs will increase at a rate of
10-12%, 3% - 5% higher than that of the GNP. The rate may decrease
somewhat, but the general rate will still keep on increasing
2. Domestic medicine finds help. Affected by the reform in Public Medicare
esp. “Pharmaceutical Reimbursement Instruction,” imported and high priced
medicines are greatly affected, and national large chemical enterprises on
the contrary find good opportunity of a new leap.
3. Over the counter (OTC) medication will develop at a high rate. Under the
double influence of the state’s policy guide and citizens’ habits of takin g
medicine, and with the quick pace of separating medicine from dosage,
OTC consumption will see further development.
The Demand for Packaging Machinery of China’s Pharmaceutical Industry
China’s big pharmaceutical companies and all of the foreign-invested manufactures
have imported processing lines of their own including advanced packaging
machinery. But China’s domestic packaging machines find more and more
obstruction when recommended to these said enterprises. With the development of
China’s pharmace utical industry, there will be great need for imported processing
lines including advanced all-auto packaging machines.
Major foreign-invested Pharmaceutical Enterprises in Mainland China
Sino-American Shanghai Squibb Pharmaceuticals Ltd.
Sino-American Tianjin SmithKline Pharmaceuticals Ltd.
Xian-Janssen Pharmaceuticals Ltd.
Shanghai Johnson & Johnson Pharmaceuticals Ltd.
Shanghai Roche Pharmaceutical Ltd.
Pfizer Pharmaceuticals Ltd.
Jinan-Hemofarm Pharmaceutical Co., Ltd.
120